C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2002
10/29/2002	CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/29/2002	CA2057699C Process for the production of (s)-vinyl and allenyl gaba
10/24/2002	WO2002083638A1 Process for the production of atorvastatin calcium in amorphous form
10/24/2002	WO2002083637A1 Process for the production of amorphous atorvastatin calcium
10/24/2002	WO2002083636A1 Pyrrolidine derivative and process for producing the same
10/24/2002	WO2002083630A1 Oxalic acid derivatives
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083622A2 Novel aminophenyl ketone derivatives
10/24/2002	WO2002083109A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002	WO2002000650A3 Novel compounds possessing antibacterial, antifungal or antitumor activity
10/24/2002	US20020156318 N-methyl-L-alanine derivatives derivatives used for preparing cell binding agent/maytansinoid complexes
10/24/2002	US20020156314 Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
10/24/2002	US20020156294 Factory scale process for producing crystalline atorvastatin trihydrate hemi calcium salt
10/24/2002	US20020156293 Process for the preparation of zofenopril calcium salt
10/24/2002	US20020156292 Anticancer agents
10/24/2002	US20020156212 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002	US20020156100 1-deoxy-galactonojirimycin and related compounds used to treat fabry disease
10/24/2002	US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002	US20020155989 Protein nucleic acid molecules
10/24/2002	US20020155505 Methods for ligand discovery
10/24/2002	CA2445538A1 Oxalic acid derivatives
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002	CA2443229A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250323A2 Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them
10/23/2002	EP1032631B1 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
10/23/2002	EP0687250B1 Method for the preparation of 1-VINYL-3(E)-ETHYLIDENE PYRROLIDONE
10/23/2002	CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002	CN1376063A Cyclic amine CCR3 antagonisis
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469171 Syntheses of a variety of lamellarin compounds and analogues
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469029 Azacycloalkanone serine protease inhibitors
10/22/2002	US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002	US6468998 Pyrrolidine compounds and medicinal utilization thereof
10/17/2002	WO2002082185A1 Perfluoroalkylsulfonic acid compounds for photoresists
10/17/2002	WO2002081448A1 Benzamidine derivative
10/17/2002	WO2002081442A2 Method for the production of δ1 pyrrolines
10/17/2002	WO2002081441A1 Process for the preparation of substituted pyrrolidine neuraminidase inhibitors
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002081426A1 Peptide deformylase inhibitors
10/17/2002	WO2002081420A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof
10/17/2002	WO2002080928A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	WO2002080905A1 Kappa opiate agonists for the treatment of bladder diseases
10/17/2002	WO2002059114A9 Lfa-1 antagonist compounds
10/17/2002	WO2002008247A3 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide
10/17/2002	US20020151724 Such as 1-((4-methoxybenzoyl-D-phenylglycinyl))-4-((isopropylamino)methyl)piperidine hydrochloride as anticoaggulants useful in the treatment of cardiovascular disorders such as thrombosis
10/17/2002	US20020151595 Carboxylic acid amides having antithrombotic activity
10/17/2002	US20020151571 Activity against arthropods in agriculture and parasites encountered in animal husbandry
10/17/2002	US20020151545 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer
10/17/2002	US20020151534 Antithrombotic compounds
10/17/2002	US20020151529 Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
10/17/2002	DE10117823A1 New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases
10/17/2002	DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair
10/17/2002	CA2443108A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
10/17/2002	CA2442904A1 Benzamidine derivative
10/16/2002	EP1249233A1 Npyy5 antagonists
10/16/2002	EP1248779A2 Glycosidase ihhibitors and preparation thereof
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0944596B1 1-acryloylindoline derivatives and their use as prodrugs of anticancer agents
10/16/2002	EP0941218B1 Antithrombotic organic nitrates
10/16/2002	EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	EP0542136B1 1-[(1,4-benzodioxanyl)alkyl]-4-(heteroaryl) piperidines, piperazines and pyrrolidines as antipsychotic agents
10/16/2002	CN1374995A Fluorescent maleimides and uses thereof
10/16/2002	CN1374948A 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same
10/16/2002	CN1374947A Synthetic reoutes for the preparation of rhionvirus protease inhibitor and key intermediates
10/15/2002	US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002	US6465433 Boronic ester and acid compounds, synthesis and uses
10/15/2002	CA2256438C Aromatic amidine derivatives useful as selective thrombin inhibitors
10/15/2002	CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/10/2002	WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002	WO2002079160A1 A process for the synthesis of an aliphatic cyclic amine
10/10/2002	WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	WO2002078679A2 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors
10/10/2002	WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002	WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002	WO2002057215A3 Sodium channel modulators
10/10/2002	WO2002043667A3 HYDROLYSIS OF [R(R,R)]-2-(4-FLUOROPHENYL)-β,δ -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE
10/10/2002	WO2001072728A9 Novel piperazine derivatives
10/10/2002	WO2001072685A9 Polyamine analogues as cytotoxic agents
10/10/2002	US20020147367 Catalytic compositions and methods for asymmetric aldol reactions
10/10/2002	US20020147342 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
10/10/2002	US20020147336 Glucocorticoid receptor modulators
10/10/2002	US20020146504 Ternary biomolecule/polymer/surface-based immobilization systems
10/10/2002	DE10133929A1 Verfahren zum Herstellen von DELTA·1·-Pyrrolinen A process for producing DELTA · 1 · -Pyrrolinen
10/10/2002	DE10116978A1 Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase Kappa-opiate agonist for the treatment of diseases of the bladder
10/10/2002	DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002	CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications

1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 404